137 related articles for article (PubMed ID: 26099427)
1. [Ocular hypertension after intravitreal steroid injections: Clinical update as of 2015].
Dot C; El Chehab H; Russo A; Agard E
J Fr Ophtalmol; 2015 Sep; 38(7):656-64. PubMed ID: 26099427
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy.
Nentwich MM; Ulbig MW
Dtsch Arztebl Int; 2012 Sep; 109(37):584-90. PubMed ID: 23093988
[TBL] [Abstract][Full Text] [Related]
4. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
5. Ocular hypertension and intravitreal steroids injections, update in 2023. French guidelines of the French glaucoma society and the French ophthalmology society.
Dot C; Poli M; Aptel F; Labbe A; Kodjikian L; Baillif S; Bodaghi B; Denis P
J Fr Ophtalmol; 2023 Oct; 46(8):e249-e256. PubMed ID: 37302867
[TBL] [Abstract][Full Text] [Related]
6. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
[TBL] [Abstract][Full Text] [Related]
7. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)].
Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599
[TBL] [Abstract][Full Text] [Related]
8. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
10. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
[TBL] [Abstract][Full Text] [Related]
11. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
12. Phaco-non-penetrating deep sclerectomy in ocular hypertension secondary to dexamethasone intravitreal implant.
Pérez-Sarriegui A; Casas-Llera P; Díez-Álvarez L; Contreras I; Moreno-López M; Figueroa MS; González-Martín-Moro J; Muñoz-Negrete FJ; Rebolleda G
Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):580-585. PubMed ID: 30266279
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
[TBL] [Abstract][Full Text] [Related]
14. Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide.
Detry-Morel M; Escarmelle A; Hermans I
Bull Soc Belge Ophtalmol; 2004; (292):45-51. PubMed ID: 15253490
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Acute Zonal Occult Outer Retinopathy With Intravitreal Steroids.
Barnes AC; Lowder CY; Bessette AP; Baynes K; Srivastava SK
Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):504-509. PubMed ID: 30021037
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone.
Tao Y; Jonas JB
Ophthalmologica; 2011; 225(1):1-20. PubMed ID: 20693817
[TBL] [Abstract][Full Text] [Related]
17. Refractory severe ocular hypertension after intravitreal triamcinolone acetonide injection.
Yang CS; Chen MJ; Chou CK; Hsu WM
Ophthalmologica; 2005; 219(6):413-5. PubMed ID: 16286805
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
[TBL] [Abstract][Full Text] [Related]
19. Incident glaucoma and ocular hypertension after periocular and intravitreal steroid injections: a claims-based analysis.
Polski A; Liu KC; Gupta D; Grewal DS; Horns J; Wirostko BM; Stagg BC
BMJ Open Ophthalmol; 2023 Dec; 8(1):. PubMed ID: 38135349
[TBL] [Abstract][Full Text] [Related]
20. Secondary ocular hypertension after intravitreal injection with 2 mg or 4 mg of triamcinolone in retinal vein occlusion.
Chuang LH; Yeung L; Wang NK; Chen HS; Ku WC; Lai CC
J Ocul Pharmacol Ther; 2010 Aug; 26(4):325-8. PubMed ID: 20653482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
